| Schedule of Measures of Segment Profit (Loss) Income |
The measures of segment profit or loss for our single reportable segment were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Net revenues from external customers(1) | $ | 103,546 | | | $ | 86,188 | | | $ | 187,225 | | | $ | 174,176 | | | | | | | | | | Significant segment expenses: | | | | | | | | | Personnel costs | 60,349 | | | 51,551 | | | 118,716 | | | 103,751 | | | Organizational and marketing costs | 16,029 | | | 14,487 | | | 31,623 | | | 28,716 | | | Inventory usage | 8,450 | | | 5,458 | | | 14,887 | | | 10,189 | | | Clinical studies and publication costs | 2,103 | | | 1,923 | | | 4,645 | | | 4,008 | | | Professional services | 2,669 | | | 2,298 | | | 5,676 | | | 5,874 | | | Other segment items | 16,006 | | | 5,948 | | | 28,260 | | | 42,963 | | | Segment (loss) income | $ | (2,060) | | | $ | 4,523 | | | $ | (16,582) | | | $ | (21,325) | |
(1)For information on disaggregation of segment revenue by type and information about payor concentration, see Note 3.
|
| Schedule of Other Amounts Included in the Measure of Segment Profit (Loss) Income |
Other amounts included in the measure of segment profit or loss were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Interest income | $ | 2,356 | | | $ | 2,944 | | | $ | 4,901 | | | $ | 6,043 | | | Interest expense | (193) | | | (21) | | | (327) | | | (38) | | | Depreciation and amortization | 4,070 | | | 3,414 | | | 7,999 | | | 33,178 | | | Income tax expense (benefit) | 370 | | | (4,666) | | | 479 | | | (5,089) | | | Stock-based compensation expense | 11,589 | | | 11,208 | | | 21,365 | | | 22,387 | | | Net (losses) gains on equity securities | (630) | | | 1,185 | | | 1,392 | | | (240) | |
|